FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.
about
CIViC databaseA place for precision medicine in bladder cancer: targeting the FGFRs.Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis.TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcomaFibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup.Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges.FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.Aberrant deleted in liver cancer-1 expression is associated with tumor metastasis and poor prognosis in urothelial carcinoma.[Urine cytology - update 2013. A systematic review of recent literature].Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer.
P2860
Q27612411-54637BA3-90DE-4B2A-A047-4B7E14A57801Q30249143-8CEAB904-CAD9-4918-91A2-3C15FFDD04B4Q33646072-DABEED9E-61C2-4A76-886B-93B44BCE96DAQ35151119-360636F9-42D0-42EF-8920-20B3C955AE2DQ36528389-C7263E73-3BDA-4D2E-A7D9-DF603024E882Q37379626-24B6C7C9-0145-429E-96AB-CF0C2BB8283DQ37687627-A2CBD977-C1BB-4942-BCBA-2C65089F1F09Q38810603-67552125-0C36-4246-8134-4A56443BFF7FQ39568069-066DECDC-EC6A-4262-AEE8-55DEAF70A667Q43115752-83829FF4-8A24-41E9-B163-3AC1644A9216Q43148228-2AC75A98-7F71-48E5-A4FA-703B439B7407Q43708178-EFB9B2F2-0D36-4276-A227-AE65332D1127Q45139625-F0E1F2F6-D098-4F63-A2CA-75E2D6177EF4Q53128013-8AE12B3B-083C-4157-B39E-698DAB9636C8Q54347333-3185245F-9696-47D1-AC0A-420980A55D40Q54348729-BD888E3E-D278-496F-9E6A-5CE201183243
P2860
FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@ast
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@en
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@nl
type
label
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@ast
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@en
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@nl
prefLabel
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@ast
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@en
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@nl
P2093
P1476
FGFR3 mutational status and pr ...... cer in a Jordanian population.
@en
P2093
Abdulhameed Ghabkari
Asem Alkhateeb
Hisham Musleh
Ismail Matalka
Khaldon Bodoor
Mohammed A Al-Ghazo
Saied Jaradat
Yazan Haddad
Ziad Jaradat
P304
P356
10.1016/J.CANEP.2010.05.003
P577
2010-12-01T00:00:00Z